Visalytics
Visalytics
approved EB-2 (NIW)

Research Fellow

Biomedical Science · China · 2025-10-20

Processing Time
633 days
Decision Date
2025-10-20
Location
Michigan
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue his research into the molecular and pathological processes underlying pancreatic cancer development to identify novel biomarkers and therapeutic targets. His work utilizes molecular and translational studies to bridge the gap between molecular biology and clinical research for improved cancer management. The endeavor aims to address high mortality rates in oncology by facilitating more effective medical interventions and precision medicine.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses pancreatic cancer, a major public health challenge with high mortality rates in the U.S.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of 12 publications, 294 citations, and extensive peer review experience demonstrates his capacity to lead this research.

3 On Balance, Beneficial to Waive Labor Certification Met

The petitioner's unique expertise in molecular mechanisms of cancer provides benefits that outweigh the need for a labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's 12 peer-reviewed journal articles which earned 294 citations, demonstrating significant influence in the field. He also provided evidence of his standing through 14 manuscript reviews and service as a guest editor for a special academic issue. The case successfully satisfied all three prongs of the Dhanasar framework by linking his molecular research to national health priorities.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Judging Experience
Original Contributions

Similar Cases

Research Assistant

Biotechnology · Malaysia

WeGreened EB-2 (NIW) approved
New York 5 days 2025-03-08
The petitioner proposes to uncover molecular and intercellular vulnerabilities in malignant tumors to combat treatment resistance, metastasis, and immune evasion. Her work specifically focuses on pancreatic ductal adenocarcinoma (PDAC) progression by examining how tumor and stromal cells interact and co-evolve using genome editing and transcriptomic profiling.
View Case

Researcher

Biotechnology · India

WeGreened EB-2 (NIW) approved
Alabama 58 days 2025-04-02
The petitioner proposes to continue her research in cancer immunology with a specific focus on the pancreatic cancer tumor microenvironment and immune modulation. Her work aims to develop methods that synergize with immunotherapies and chemotherapies to enhance treatment efficacy and improve patient outcomes. She intends to continue publishing high-impact research to advance the field of biomedical science in the United States.
View Case

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
Maryland 470 days 2025-02-28
The petitioner proposes to continue research in molecular biology focusing on the roles of specific proteins and signaling pathways in cancer development. The work involves studying compounds that disrupt survival signals in cancer cells to design highly effective, targeted therapies. The goal is to improve patient survival rates and enhance the precision of cancer treatments globally.
View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) rfe approved
California 612 days 2025-08-21
The petitioner proposes to build bioinformatics tools to uncover mechanisms driving cancer development and progression. Her work integrates single-cell analysis, transcriptomics, and machine learning to improve therapeutic strategies and inform precision medicine. The endeavor aims to reduce the national burden of cancer and enhance drug discovery efforts.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-10-20.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 633 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist